quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 19, 2026

Stellar Projects Publishes “Créer sa marque à l’ère de l’IA” and Cements Its Position as France’s Leading Shopify Agency

View original at globenewswire.com
Stellar Projects Publishes “Créer sa marque à l’ère de l’IA” and Cements Its Position as France’s Leading Shopify Agency Paris, PARIS, March 19, 2026 (GLOBE NEWSWIRE) -- Stellar Projects, a certified Shopify and Shopify Plus Partner agency founded in 2018, today announces the release of “Créer sa marque à l’ère de l’IA…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Generative AI is embedded at virtually every stage of brand creation in 2026: branding, producing visual assets and mockups, writing product copy and SEO content, optimizing advertising campaigns, and running predictive analysis on customer cohorts

    60% confidence
  • Until now, no French-language guide covered the full journey from brand positioning through to a high-performing Shopify store launch, with AI embedded at every step

    60% confidence
  • Integrating AI into brand creation is no longer a competitive advantage — it is a condition of survival in a market where launch cycles are compressing.

    60% confidence
  • Until now, no French-language guide covered the full journey from brand positioning through to a high-performing Shopify store launch, with AI embedded at every step.

    60% confidence
  • The book stands as the only French-language guide combining Shopify development, brand strategy, and applied generative AI for ambitious brand builders

    60% confidence
  • Integrating AI into brand creation is no longer a competitive advantage — it is a condition of survival in a market where launch cycles are compressing

    60% confidence
  • Most resources on e-commerce brand building are either highly theoretical or completely disconnected from the reality of a founder managing margins, inventory, marketing campaigns, and Shopify development simultaneously

    60% confidence
  • We wrote this book because it simply did not exist in French. Most resources on e-commerce brand building are either highly theoretical or completely disconnected from the reality of a founder managing margins, inventory, marketing campaigns, and Shopify development simultaneously.

    60% confidence
  • In 2026, generative AI is embedded at virtually every stage of brand creation: branding, producing visual assets and mockups, writing product copy and SEO content, optimizing advertising campaigns, and running predictive analysis on customer cohorts.

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com